2O'Dell JR. Left R, Paulsen G, et al. Trealment of rheumatoid arthritis with methotrexate and hydmxyehloroqulne, methotrexate and sulfasalazine, or a combination of the three medications: results of a two - year. randomized, double - blind, placebo - controlled trial. Arthritis Rheum, 2002, 46(5): 1164 - 1170.
3Kremer JM. Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arlhritis despite stable doses of merhotrexate. A randomized, double- blind,placebo - controlled trial. Ann Intern Med, 2002, 137(9): 726 -733.
4Totokawa S. Furuya T, Nakajima A, et al. Effects of low dose methotrexate Iherapy in rheumaloid arthritis: a comparison of three different dosage regimens. Ryumachi, 1997, 37 (5): 681 -687.
5Glennas A, Kvien TK, Andrup O, et al. Auranofin is safe and superior to placebo in elderly - onset rheumatoid arthritis. Br J Rheum, 1997, 36:870 - 877.
6Favalli EG, Sinigaglia L, Varenna M, et al. Drug- induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus,2002, 11 ( 11 ) :753 - 755.
7Brown SL, Greene MH, Gershon SK. et al. Tumor necrosis factor antagonist therapy and lymphnma development: twenty- six cases reported to the Food and Drug administration. Arthritis Rheum, 2002,46( 12): 3151 - 3158.
8Lockie LM, Gomez E, Smith DM.Low dose adrenocorticosteroids in the management of elderly patients and summary of efficacy in the long-term treatment of 97 patients .Semin Arthritis Rheum,1983,12(4):373 - 381.
9Conn DL,Lim SS. New role for an old friend: prednisone is a disease- modifying agent in early RA. Curr Opin Rheumatol, 2003,15(3): 2193 -2196.
10ACR Subcommittee on rheumatoid arthrilis guidelines, Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 2002, 46(2): 328 - 346.
